Ex vivo measurement of calpain activation in human peripheral blood lymphocytes by detection of immunoreactive products of calpastatin degradation

Folia Histochemica et Cytobiologica

Volumn 45, Issue 4, 2007, Pages 343-347

  Mikosik, Anna ^a   Zaremba, Anna ^a   Puchalska, Zofia ^a   Daca, Agnieszka ^a   Smoleńska, Zaneta ^a   Łopatniuk, Paulina ^a   Mital, Andrzej ^a   Hellmann, Andrzej ^a   Bryl, Ewa ^a   Witkowski, Jacek M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Calpain; Calpastatin; Cysteine proteases; Ex vivo; Lymphocytes

Indexed keywords

CALPAIN; CALPASTATIN; CD19 ANTIGEN; CD4 ANTIGEN;

ARTICLE; B CELL LEUKEMIA; CD4+ T LYMPHOCYTE; CELL ISOLATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PERIPHERAL LYMPHOCYTE; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; WESTERN BLOTTING;

EID: 38849118351     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Huang Y, Wang KW. The calpain family and human disease. Trends Mol Med. 2001;7:355-362.
2. Lu T, Xu Y, Mericle MT, Mellgren RL. Participation of convencional calpins in apoptosis. Biochim Biophys Acta. 2002; 1590:16-26.
3. Sazonowa TG, Matskevich AA, Arkhipenko YV. Calpains: physiological and pathophysiological signicance. Pathophysiology. 1999;6:91-102.
4. Suzuki K, Sorimachi H, Yoshizawam T, Kinbara K, Ishiura S. Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe Seyler. 1995;376:523-529.
5. Kinbara K, Ishiura S, Tomioka S, Sorimachi H, Jeong SY, Amano S, Kawasaki H, Kolmerer B, Kimura S, Labeit S, Suzuki K. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. Biochem J. 1998; 335:589-596.
6. Guroff G. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem. 1964;239:149-155.
7. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J. 1997;328:721-732.
8. Tan Y, Wu C, De Veyra T, Greer PA. Ubiquitous calpains promote both apoptosis and survival signals in responses to different cell death stimuli. J Biol Chem. 2006;281(26): 17689-98.
9. Shi Y, Melnikov VY, Schrier RW, Edelstein CL. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol. 2000; 279:509-517.
10. Chua BT, Gui K, Li P. Direct Cleavage by the Calcium-activated Protease Calpain Can Lead to Inactivation of Caspases. J Biol Chem. 2000;7:5131-5135.
11. Porn-Ares MI, Samali A, Orrenius S. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 1998; 5:1028-1033.
12. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83(3):731-801
13. Schwarz-Benmeir N, Glaser T, Barnoy S, Kosower NS. Calpastatin in erythrocytes of young and old individuals. Biochem. J. 1994;304:365-370.
14. Witkowski JM, Zmuda-Trzebiatowska E, Świercz JM, Cichorek M, Ciepłuch H, Lewandowski K, Bryl E, Hellman A. Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood. 2002;100:1802-1809.
15. Raser KJ, Posner A, Wang KK. Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents. Arch Biochem Biophys. 1995;319(1):211-216.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-685.
17. Drag-Zalesinska M, Wysocka T, Dumanska M, Jagoda E, Zabel M. Comparison of techniques permitting to detect apoptosis in situ. Folia Histochem Cytobiol. 2002;40(2): 125-126.
18. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535): 37-43.
19. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81(5):801-809.